[CERS] Cerus Corporation


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 4.66 Change: 0.26 (5.91%)
Ext. hours: Change: 0 (0%)

chart CERS

Refresh chart

Strongest Trends Summary For CERS

CERS is in the medium-term down -24% below S&P in 1 year and down -37% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Cerus Corporation, together with its subsidiary, Cerus Europe B.V., operates as a biomedical products company in Europe, the Commonwealth of Independent States, and the Middle East. The company develops and commercializes the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, including viruses, bacteria, and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company?s INTERCEPT Blood System for platelets is designed to inactivate blood-borne pathogens in platelets donated for transfusion; INTERCEPT Blood System for plasma is designed to inactivate blood-borne pathogens in plasma donated for transfusion; and INTERCEPT Blood System for red blood cells is designed to inactivate blood-borne pathogens in red blood cells donated for tran

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-0.63 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -10.57% Sales Growth - Q/Q-19.77% P/E-3.54
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-33.51% ROE-43.65% ROI-39.88%
Current Ratio5.99 Quick Ratio5.29 Long Term Debt/Equity0.08 Debt Ratio0.21
Gross Margin40% Operating Margin-137.01% Net Profit Margin-132.42% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities76.5 M Cash From Investing Activities-65.59 M Cash From Operating Activities-15.75 M Gross Profit2.98 M
Net Profit-9.46 M Operating Profit-14.37 M Total Assets143.22 M Total Current Assets136.42 M
Total Current Liabilities22.76 M Total Debt9.88 M Total Liabilities33.29 M Total Revenue7.69 M
Technical Data
High 52 week6.85 Low 52 week4.09 Last close4.34 Last change0.46%
RSI49.67 Average true range0.21 Beta0.97 Volume739.37 K
Simple moving average 20 days-0.37% Simple moving average 50 days-6.27% Simple moving average 200 days-19.92%
Performance Data
Performance Week0.7% Performance Month-1.59% Performance Quart-19.63% Performance Half-15.07%
Performance Year-14.9% Performance Year-to-date-14.4% Volatility daily2.77% Volatility weekly6.19%
Volatility monthly12.68% Volatility yearly43.91% Relative Volume436.07% Average Volume882.94 K
New High New Low


2020-05-27 12:00:04 | Cerus CERS Upgraded to Buy: What Does It Mean for the Stock?

2020-05-26 08:30:00 | Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex

2020-05-07 12:15:43 | Cerus Corporation NASDAQ:CERS Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

2020-05-06 07:33:36 | Cerus Corporation CERS Q1 2020 Earnings Call Transcript

2020-05-06 02:28:57 | Edited Transcript of CERS earnings conference call or presentation 5-May-20 8:30pm GMT

2020-05-05 18:45:10 | Cerus CERS Reports Q1 Loss, Tops Revenue Estimates

2020-05-05 16:01:00 | Cerus Corporation Announces First Quarter 2020 Results

2020-05-04 08:30:00 | Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits

2020-04-29 10:05:02 | Moving Average Crossover Alert: Cerus

2020-04-28 12:34:04 | Will Cerus CERS Report Negative Earnings Next Week? What You Should Know

2020-04-24 08:30:00 | Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020

2020-04-23 11:43:03 | Cerus Corporation CERS Shares March Higher, Can It Continue?

2020-04-20 17:50:00 | Cerus Corporation Announces Expansion of BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells

2020-04-07 08:40:07 | Introducing Cerus NASDAQ:CERS, The Stock That Dropped 26% In The Last Year

2020-04-06 08:30:00 | Cerus Corporation Provides Update on COVID-19 Related Activities

2020-04-02 08:30:00 | University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent Plasma

2020-04-02 08:30:00 | Cerus Corporation Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Preparation of COVID-19 Convalescent Plasma

2020-03-26 08:30:00 | Cerus Forms Group to Research Optimal Production of COVID-19 Convalescent Plasma

2020-03-02 16:10:00 | Cerus Corporation Announces Strategic Organizational Changes

2020-02-25 15:25:00 | 18 Medical Stocks To Watch Amid The Coronavirus Outbreak

2020-02-25 08:30:00 | Cerus Corporation to Participate in Upcoming Investor Conferences

2020-02-22 07:58:46 | Cerus Corporation Just Reported, And Analysts Assigned A US$8.25 Price Target

2020-02-21 21:28:29 | Edited Transcript of CERS earnings conference call or presentation 20-Feb-20 9:30pm GMT

2020-02-20 16:01:00 | Cerus Corporation Announces Record Fourth Quarter and Full Year 2019 Financial Results

2020-02-18 08:30:00 | U.S. Department of Defense Awards Funding for Study to Evaluate the Use of INTERCEPT Plasma in Traumatic Burn Resuscitation

2020-02-12 08:30:00 | Cerus Corporation to Release Fourth Quarter and Full Year 2019 Financial Results on February 20, 2020

2020-02-06 06:06:01 | Trade Alert: The Independent Director Of Cerus Corporation NASDAQ:CERS, Franklin Witney, Has Just Spent US$100k Buying Shares

2020-01-31 16:01:00 | Cerus Corporation Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

2020-01-29 09:00:00 | Cerus Corporation Announces Pricing of Upsized Public Offering of Common Stock

2020-01-28 16:01:00 | Cerus Corporation Announces Public Offering of Common Stock

2020-01-23 13:02:09 | 13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak

2020-01-23 08:30:00 | Coronavirus Inactivation Reported in Recent INTERCEPT Blood System Publication in Transfusion Medicine

2020-01-21 08:30:00 | French Hemovigilance Report Highlights Safety and Effectiveness of INTERCEPT Platelets During First Full Year of 100% Production and Routine Use

2020-01-13 08:30:00 | Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2019 Product Revenue

2019-12-30 14:08:49 | Is Cerus NASDAQ:CERS Using Debt Sensibly?

2019-12-16 16:38:51 | Cerus Corporation CERS: Are Hedge Funds Right About This Stock?

2019-12-12 08:30:00 | Cerus Corporation Announces New Five-Year INTERCEPT Blood System Agreement With Swiss Transfusion SRC

2019-11-13 08:30:00 | Cerus Corporation to Present at the Stifel 2019 Healthcare Conference

2019-11-12 06:45:12 | How Should Investors React To Cerus Corporation's NASDAQ:CERS CEO Pay?

2019-11-08 08:30:00 | Cerus Corporation to Present at the Stephens Nashville Investment Conference

2019-11-01 09:34:11 | Were Hedge Funds Right About Cashing Out Of Cerus Corporation CERS?

2019-11-01 07:38:56 | The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance

2019-10-31 12:41:23 | Edited Transcript of CERS earnings conference call or presentation 30-Oct-19 8:30pm GMT

2019-10-30 18:45:10 | Cerus CERS Reports Q3 Loss, Tops Revenue Estimates

2019-10-30 16:01:00 | Cerus Corporation Announces Third Quarter 2019 Results

2019-10-23 10:34:02 | Will Cerus CERS Report Negative Earnings Next Week? What You Should Know

2019-10-21 08:30:00 | Cerus Corporation to Release Third Quarter 2019 Results and to Discuss Recent FDA Guidance for Bacterial Safety of Platelets on October 30, 2019

2019-10-18 08:30:00 | Cerus Corporation Announces Schedule of Presentations at the 2019 AABB Annual Meeting

2019-10-13 09:36:37 | How Much Are Cerus Corporation NASDAQ:CERS Insiders Taking Off The Table?

2019-09-30 12:00:00 | Cerus Corporation Applauds the Publication of the Final Guidance Document on Bacterial Safety Standards for Platelet Collection and Transfusion